BAKER BROS. ADVISORS LP - Director at TScan Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
TCRX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by BAKER BROS. ADVISORS LP since 14 Oct 2025

Reported holdings for BAKER BROS. ADVISORS LP in TScan Therapeutics, Inc.

Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TScan Therapeutics, Inc.

Security class
Non- Qualified Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
20 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for BAKER BROS. ADVISORS LP in TScan Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .